Related Experiment Videos
Nasal polyps treatment: medical management
1Department of Otorhinolaryngology, Rigshospitalet, Copenhagen, Denmark.
Allergy and Asthma Proceedings
|September 1, 1996
Summary
Glucocorticosteroids (steroids) are key for managing nasal polyposis symptoms and reducing polyp recurrence. Topical steroids offer long-term benefits, while systemic steroids provide short-term relief for severe cases.
Area of Science:
- Otolaryngology
- Allergy and Immunology
- Pharmacology
Background:
- Nasal polyposis presents challenges in symptom management, nasal breathing, olfaction, and recurrence prevention.
- While antibiotics address complications, glucocorticosteroids (steroids) are the primary medical treatment for nasal polyposis signs and symptoms.
Purpose of the Study:
- To outline the objectives of medical management for nasal polyposis.
- To review the efficacy and application of topical and systemic steroids in treating nasal polyposis.
- To discuss the combination of therapies for individualized nasal polyposis management.
Main Methods:
- Review of controlled trials on topical steroid efficacy.
- Analysis of studies on systemic steroid effects and limitations.
- Examination of treatment strategies combining topical steroids, systemic steroids, and surgery.
Main Results:
- Topical steroids effectively reduce rhinitis symptoms, improve nasal breathing, decrease polyp size, and lower recurrence rates.
- Topical steroids have minimal impact on the sense of smell and sinus pathology.
- Systemic steroids impact all symptoms, including olfaction, but are reserved for short-term use due to adverse effects.
Conclusions:
- Topical steroids are a well-studied long-term option for mild nasal polyposis, or in combination for severe cases.
- Systemic steroids offer short-term "medical polypectomy" benefits but require caution.
- Optimal individualized management involves combining long-term topical steroids, short-term systemic steroids, and surgery, though precise combinations require further research.